ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,542Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 717

$934K Total Retail Price of All Prescriptions

Rank: 12 out of 717

388 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 388 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 12,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 573 558 1 5
AMLODIPINE BESYLATE 572 550 2 2
CARVEDILOL 536 535 3 6
METOPROLOL SUCCINATE 521 499 4 1
DIOVAN 397 396 5 13
CRESTOR 393 383 6 11
ATORVASTATIN CALCIUM 383 366 7 4
RAMIPRIL 360 344 8 15
SIMVASTATIN 316 300 9 3
POTASSIUM CHLORIDE 292 280 10 27
DIGOXIN 282 262 11 14
LEVOTHYROXINE SODIUM 280 280 12 23
NEXIUM 249 241 13 37
OMEPRAZOLE 238 238 14 28
LOVAZA 236 215 15 33
LOSARTAN POTASSIUM 232 211 16 16
WARFARIN SODIUM 221 212 17 7
TRAMADOL HCL 214 211 18 61
METOPROLOL TARTRATE 200 194 19 8
DIOVAN HCT 200 200 19 26
ZOLPIDEM TARTRATE 142 142 21 35
DONEPEZIL HCL 139 139 22 57
RANEXA 139 139 22 42
PLAVIX 133 133 24 12
CLONIDINE HCL 129 129 25 48
JANUVIA 129 129 25 52
TEKTURNA 119 107 27 107
CLOPIDOGREL 119 119 27 10
LIPITOR 117 116 29 19
PANTOPRAZOLE SODIUM 101 86 30 49
LOSARTAN-HYDROCHLOROTHIAZIDE 97 95 31 34
BISOPROLOL FUMARATE 96 87 32 47
ALENDRONATE SODIUM 94 94 33 69
METFORMIN HCL 90 80 34 30
ENALAPRIL MALEATE 90 86 34 24
CHLORTHALIDONE 89 77 36 84
ALLOPURINOL 88 87 37 56
PRADAXA 88 80 37 22
TRILIPIX 87 87 39 72
POLYETHYLENE GLYCOL 3350 84 84 40 168
NITROGLYCERIN PATCH 82 82 41 43
AZITHROMYCIN 81 77 42 55
IBANDRONATE SODIUM 80 80 43 155
ATENOLOL 78 78 44 18
DEXILANT 75 75 45 108
ISOSORBIDE MONONITRATE ER 74 74 46 20
NAMENDA 73 73 47 78
WELCHOL 72 68 48 89
MECLIZINE HCL 66 66 49 103
OXYCODONE-ACETAMINOPHEN 64 61 S2 50 88
SPIRONOLACTONE 62 62 51 31
DILTIAZEM 24HR CD 57 50 52 46
MICARDIS 56 56 53 92
XARELTO 56 56 53 64
KLOR-CON 10 56 56 53 86
NITROSTAT 56 55 53 44
SINGULAIR 55 51 57 95
KLOR-CON M10 55 55 57 134
LIDODERM 52 52 59 105
FLUTICASONE PROPIONATE 52 52 59 110
ACTONEL 51 51 61 142
TAMSULOSIN HCL 51 51 61 70
LANSOPRAZOLE 50 49 63 264
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.